|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.63 CAD||0.03 (+5.00%)||0.445 - 2.31||41.3 thousand (Below Avg)|
Market data as of 3:53PM 12/19/14. Quotes are delayed by at least 15 min.
Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® and Checkpoint Inhibitor Combination Preclinical Data at AACR Tumor Immunology and Immunotherapy Conference
PR Newswire - Thursday 12/04/2014 6:30 AM ET
Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers
PR Newswire - Tuesday 12/02/2014 6:30 AM ET
Media Advisory - Oncolytics Biotech® Inc. to Participate in the Stifel 2014 Healthcare Conference
PR Newswire - Tuesday 11/18/2014 6:30 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.